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112870 | RSC Adv., 2016, 6, 112870–112d “backbone ﬂuorescence” in
protein three-dimensional ﬂuorescence spectra
Annalisa Bortolotti,†a Yin HowWong,†b Stine S. Korsholm,‡c Noor Haﬁzan B. Bahring,b
Sara Bobone,§a Saad Tayyab,*b Marco van de Weert*c and Lorenzo Stella*a
In this study, several proteins (albumin, lysozyme, insulin) and model compounds (Trp, Tyr,
homopolypeptides) were used to demonstrate the origin of the ﬂuorescence observed upon their
excitation at 220–230 nm. In the last 10 years we have observed a worrying increase in the number of
articles claiming that this ﬂuorescence originates from the protein backbone, contrary to the established
knowledge that UV protein emission is due to aromatic amino acids only. Overall, our data clearly
demonstrate that the observed emission upon excitation at 220–230 nm is due to the excitation of Tyr
and/or Trp, with subsequent emission from the lowest excited state (i.e. the same as obtained with
280 nm excitation) in agreement with Kasha's rule. Therefore, this ﬂuorescence peak does not provide
any information on backbone conformation, but simply reports on the local environment around the
aromatic side chains, just as any traditional protein emission spectrum. The many papers in reputable
journals erroneously reporting this peak assignment, contradicting 5 decades of prior knowledge, have
led to the creation of a new dogma, where many authors and reviewers now take the purported
backbone ﬂuorescence as an established fact. We hope the current paper helps counter this new
situation and leads to a reassessment of those papers that make this erroneous claim.Introduction
Fluorescence spectroscopy is a commonly used and powerful
method to study protein conformational changes, by taking
advantage of the emission properties of aromatic residues, in
particular tryptophan (Trp).1,2 Among many diﬀerent uores-
cence approaches, three-dimensional (3D) uorescence spectra,
also called excitation–emission matrices or total uorescence,
represent a powerful tool to analyse complex samples. In this
technique, emission intensity is measured for all possible
combinations of excitation and emission wavelengths, thus
summarizing in a single 3D plot the information corresponding
to many diﬀerent excitation and emission spectra.3–7 This
approach is very useful in analysing samples containingmiche, Universita` di Roma Tor Vergata,
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876multiple uorophores with overlapping spectra, such as
wastewaters.8
In a large number of papers, primarily published in the last
10 years, 3D uorescence spectra have also been used to char-
acterize ligand–protein interactions, and specically the
purported conformational changes induced by the association.
Among other components, 3D uorescence spectra of proteins
usually exhibit a peak with an excitation maximum at 220–
230 nm, and an emission maximum at 300–350 nm, the exact
peak position depending on the specic protein and the uo-
rimeter used (see Fig. 1 for selected examples of human serum
albumin (HSA), lysozyme and human insulin). Surprisingly, in
a large number of recent papers this peak has been alleged to
originate from the protein backbone and its properties (inten-
sity and position) to be sensitive to conformational changes of
that backbone. For example, an analysis of 176 articles pub-
lished in 2012 and dealing with uorescence studies of ligand
binding to albumin revealed that 24 of those, published in 14
diﬀerent journals, assigned a peak in 3D uorescence spectra to
backbone emission.9 Also in 2016 many examples of papers
making the same claim can be found in the literature.10–26 These
latter references are solely meant as examples of the widespread
nature of the backbone uorescence claim and are not an all-
inclusive list. More importantly, we would like to point out
that 3D uorescence spectra are simply one of the many
experiments reported in those articles. Here we wish to
comment only on the use of this particular technique. It shouldThis journal is © The Royal Society of Chemistry 2016
Fig. 1 Normalised 3D ﬂuorescence spectra/contour maps of diﬀerent proteins and of a buﬀer solution. Top row: 3D ﬂuorescence spectrum of
HSA (DK). Middle row: contour maps for HSA collected under diﬀerent experimental conditions and using diﬀerent instruments (see Materials
and methods) in MY (left), DK (centre) and IT (right). Bottom row: lysozyme (MY, left), insulin (DK, centre) and buﬀer (IT, right). The peak labels are
described in the main text. Fluorescence intensities of all spectra were normalised to 100 on peak ‘1’, with the exception of the buﬀer spectrum,






















































































View Article Onlinealso be noted that some other reports describe self-assembly
induced emission in the visible region by peptides in brillar
or other aggregated states. The still-debated origin of this
phenomenon has been recently attributed to proton transfer
through intermolecular hydrogen bonds, which could take
place only in very specic structures.27 However, here we will
limit our discussion to the claim that all protein backbones
emit in the UV region.
This claim is actually extremely surprising, as it contradicts
half a century of prior knowledge. Already in 1952, Debye and
Edwards demonstrated that protein phosphorescence is due to
the aromatic residues only.28 In 1953 Gregorio Weber postu-
lated, on the basis of general considerations of the properties of
aromatic amino acids and the positions of their absorption
maxima, that protein uorescence originates from aromatic
amino acids, too.29 This hypothesis was shortly aerwards
conrmed by ground-breaking experimental studies.30–32 In
1967,32 Konev summarized the pioneering years of protein
uorescence studies as follows: “The exclusively aromatic
nature of protein uorescence was conclusively shown by
experiments in which no uorescence could be detected in
proteins which contain no aromatic amino acids. It can now
be regarded as established that the formation of uorescence
and phosphorescence spectra of proteins involves only three
aromatic amino acids which are capable of luminescence in the
free state. These are tryptophan, tyrosine, and phenylalanine”.
Also several more recent papers discuss uorescence ob-
tained by far-UV excitation (220–230 nm range) in the context ofThis journal is © The Royal Society of Chemistry 2016excitation and emission by the Tyr and Trp residues.33–35 Thus,
in a historical perspective the observation of uorescence from
the protein backbone is a potentially exciting new nding.
Unfortunately, an examination of the references used to
substantiate this claim reveals no study that directly investi-
gated this phenomenon. If a reference is provided at all, it is to
papers that make the same claim, or to papers reporting that
the protein backbone absorbs UV-radiation in a broad range
between 200 and 250 nm. However, also the aromatic amino
acids absorb in this range. We tried to nd the original article
where backbone emission was rst proposed, and identied
a work by Zhang et al.36 as a likely rst. Here, the authors
speculated that, since the backbone absorbs in the far UV
region, then the 3D peak “may mainly exhibit the uorescence
characteristic of polypeptide backbone structures”. The only
data reported to support this hypothesis was the decrease in
peak intensity with increasing protein concentration. This
nding, which is in reality likely arising from inner-lter
eﬀects,37 was interpreted as the result of the interaction
between peptide chains. One of the authors on the current
paper was also misled by the aforementioned conclusion in
peak assignment.38 It is rather remarkable that the large
number of studies using 3D uorescence spectra to study
structural changes of proteins upon ligand binding are based
on such insubstantial evidence, against a large historical body
of studies stating the opposite.
There are a number of further reasons that cast doubt on the






















































































View Article Online(1) Very few molecules are measurably uorescent, due to the
fact that non-radiative decay processes usually predominate over
the emission of a photon in the relaxation of excited molecules.
Although it is still diﬃcult to predict theoretically which mole-
cules will exhibit uorescence,39 uorescent compounds are
aromatic, or (less oen) highly unsaturated aliphatic molecules.
Delocalized electrons, formally present in conjugated double
bonds, are required for providing the rigidity necessary to inhibit
non-radiative relaxation processes.40–42 No extended conjugated
systems are present in the peptide backbone and the low wave-
length region of peptide absorption at around 220 nm is due to
an n/ p* transition,43 which is forbidden in the electric dipole
approximation. Both these points argue against the backbone
showing any uorescence.40–42
(2) In their seminal 1957 article on the origin of protein
uorescence, Teale and Weber30 indicated that an important
criterion to verify “whether the uorescence shown by a solu-
tion is due to a given substance present in it” is a good match
between the uorescence excitation spectrum and the absorp-
tion of the putative uorophore. By contrast, the protein back-
bone has an absorption maximum around 190 nm,
corresponding to a p/ p* transition of the amide band,44 and
therefore does not match with the 220–230 nm excitation peak
observed in 3D uorescence spectra.
(3) Fluorescence is always observed at wavelengths longer
than those of the lowest energy absorption band. This
phenomenon, called Stokes shi,45 is largely due to diﬀerential
solvation of the excited and ground states (in addition to
vibrational relaxation phenomena). Therefore, the solvent-
induced shis of emission bands can be used to calculate
dipole moments of electronically excited molecules.46 An
absorption–emission shi from 220 to 340 nm would corre-
spond to a Stokes shi of approximately 2 eV in energy. This
shi would be much larger than the record shis reported for
charge transfer compounds such as 6-propionyl-2-(N,N-dime-
thylamino)naphthalene (PRODAN)47 or 4-dimethylamino-40-
nitrostilbene (DANS),48 which undergo an exceptional dipole
increase following excitation.
For all the reasons explained above, it should be clear that
the peak 220–230/300–350 nm peak observed in 3D uorescence
spectra of proteins cannot be due to backbone emission. To
make this point clear from an experimental point of view, we
collected 3D uorescence spectra for diﬀerent proteins and
model compounds. These data will allow us to fully clarify all
the features commonly observed in 3D uorescence spectra of
proteins. Samples were analysed independently in diﬀerent
laboratories around the world (Denmark, Italy, and Malaysia).
Experiments were performed on diﬀerent uorimeters and
using diﬀerent settings, to show the robustness of the obser-
vations and of the conclusions drawn, and to illustrate the
diﬀerences that can be observed in 3D uorescence spectra due
to diﬀerent experimental settings and instrumentation.
Materials and methods
In this section, diﬀerences between the three groups are indi-
cated by the two letter code of the relevant country (DK, IT, MY).112872 | RSC Adv., 2016, 6, 112870–112876Materials
Human serum albumin (HSA), lysozyme from chicken egg
white, L-tryptophan (Trp), L-tyrosine (Tyr), poly-DL-alanine (Poly-
A), recombinant human insulin, poly-L-lysine (Poly-K), bicin-
choninic acid (BCA) kit for protein determination and sodium
hydrogen phosphate were purchased from Sigma Aldrich (USA).
Octa-L-arginine was from GenScript Corp. (Piscataway, NJ).
Sodium dihydrogen phosphate was obtained from VWR
(Leuven, Belgium) (DK) or Sigma Aldrich (USA) (IT).UV spectroscopy
UV-visible spectra were acquired using: a V-770 (Jasco) (IT),
a Nanodrop 2000C (Thermo Scientic) (DK) or a UV-2450 (Shi-
madzu) (MY) spectrophotometer.Sample preparation
All samples (IT, DK) were dissolved in sodium phosphate buﬀer
(10 mM, pH 7.4), except the insulin solution that was prepared
by rst dissolving 5 mg in 80 ml of 0.1 M HCl, then neutralized
using 80 ml of 0.1 M NaOH and then diluted using ca. 5 ml of
phosphate buﬀer. This sample was then ltered through a 0.22
mm lter. All samples (MY) were prepared in Milli-Q water
except for Tyr and Trp, which were dissolved in 1 MHCl, diluted
with Milli-Q water and neutralized with NaOH.
The concentrations of the samples containing aromatic
moieties were determined spectrophotometrically using molar
extinction coeﬃcients of 5630 cm1 M1 at 280 nm for Trp,49
35 200 cm1 M1 at 280 for HSA,49 38 940 cm1 M1 at 280 nm
for lysozyme,50 6200 cm1 M1 at 276 nm for insulin,51 and 1295
cm1 M1 at 278 nm for Tyr.49
Poly- and oligo-peptide concentrations were determined by
weighing the dissolved powder in the case of octa-L-arginine
(DK), by absorbance at 214 nm for Poly-K (IT), using an
extinction coeﬃcient of 923 cm1 M1 for the monomer,52 or by
the bicinchoninic acid method53 for Poly-A and Poly-K solutions
(MY), using bovine serum albumin as a standard, whose
concentration was determined spectrophotometrically, with an
extinction coeﬃcient of 43 900 cm1 M1 at 280 nm.49
Concentrations used in the 3D spectra were: HSA 0.9 mM (IT).
1.5 mM (DK) or 3 mM (MY); lysozyme 4 mM (MY); insulin 17 mM
(DK); Trp 0.9 mM (IT) or 3 mM (MY); Tyr 3 mM; Poly-A 0.2 mg
ml1; octa-L-arginine 0.2 mg ml1; Poly-K 0.2 mg ml1
(including the Br counter ion).Fluorescence spectroscopy
Fluorescence spectra were collected with a Cary Eclipse uo-
rescence spectrometer (Agilent Technologies) (IT and DK), or
a FP-6500 spectrouorimeter (Jasco) (MY). Both these instru-
ments have also been used by several of the authors claiming
the presence of backbone uorescence. Experiments were per-
formed in 1 cm path length cells. 3D uorescence spectra were
executed under the following conditions: excitation 220–
350 nm; emission 220–450 nm; data interval 2 nm (IT, DK) or
5 nm in excitation and 1 nm in emission (MY); bandwidth






















































































View Article Onlinemin1 (IT), 1200 nm min1 (DK) or 500 nm min1 (MY). In the
Cary the detector voltage was set at 800 V (IT) or 600 V (DK),
while it was xed at 250 V (MY) in FP-6500. Blank subtraction or
spectral corrections were not performed. Fluorescence emission
or excitation spectra were executed under the same conditions
of the 3D spectra (DK) or with the following settings (IT): data
interval 1 nm, excitation bandwidth 5 nm, emission bandwidth
10 nm, scan rate 30 nm min1, detector voltage 600 V. Excita-
tion spectra were corrected for inner lter eﬀects.54
Results and discussion
3D uorescence spectra of proteins
Fig. 1 reports the normalised 3D uorescence spectra/contour
plots of three representative proteins: HSA, lysozyme and
human insulin. These molecules are very diverse in size (585,
129 and 51 amino acid residues, respectively), and aromatic
amino acid composition: Phe dominates in HSA (1 Trp, 18 Tyr
and 31 Phe), Trp in lysozyme (6 Trp, 3 Tyr and 3 Phe), while
insulin only contains Tyr and Phe (4 Tyr and 2 Phe).
The 3D uorescence spectra of HSA collected in the three
laboratories participating in the present study show that the
relative intensities of the diﬀerent peaks and even their exact
position can vary due to inner lter eﬀect and instrumental
factors, such as the wavelength response of monochromators
and detectors. Corrections for these factors are in principle
possible,1,55 but were not performed in the current study, as it is
customary to report uncorrected, so-called “technical” spectra,
particularly for 3D uorescence.1 Therefore, the multiple data-
sets reported here serve to illustrate possible variations in the
spectral shape, due to instrumental factors. Indeed, a variability
in exact peak positions and relative intensities similar to those
observed in our three labs can also be noticed among the papers
claiming backbone uorescence.10–26
Some of the signals in the 3D uorescence spectra are not
due to uorescence, but to light scattering, and can therefore be
observed also for a sample that does not contain any uo-
rophore, such as buﬀer or pure water. The line labelled as ‘a’,
corresponding to the matrix diagonal, i.e. the region with lem.¼
lexc., is due to elastic scattering of the excitation light by the
sample solvent, the dissolved molecules, and suspended
particulates. A second line, labeled as ‘b’, is observed at lem. ¼
2lexc., and is due to an instrumental artefact caused by trans-
mission of second-order diﬀraction by grating mono-
chromators. That is, when set to select a given wavelength, l,
a grating monochromator also partially transmits light with
wavelength l/2.1,56 For these reasons, peak ‘b’ actually corre-
sponds to light of wavelength lem. ¼ lexc. that can cross the
emission monochromator, when this is set at lem. ¼ 2lexc..
Another much weaker line is sometimes visible (depending
on the uorescence intensity scale), and is due to inelastic
(Raman) scattering by the solvent. In this phenomenon,
photons lose an amount of energy corresponding to the energy
needed to excite vibrations of the solvent molecules. Therefore,
the energy diﬀerence between the incident and scattered light
(as the wavelength of the rst is varied in a scan) is constant. A
constant energy diﬀerence corresponds to a varying diﬀerenceThis journal is © The Royal Society of Chemistry 2016in wavelengths. Therefore, Raman scattering is responsible for
the line labelled as ‘c’ in the Fig. 1, which runs close to line ‘a’,
but is not parallel to it.
The remaining two peaks, designated as peaks ‘1’ and ‘2’ in
the 3D uorescence spectra, are due to protein uorescence.
The comparison of the three HSA 3D uorescence spectra shows
that the relative intensities of these two peaks with respect to
the scattering signals is dependent on protein concentration (in
addition to the aforementioned experimental factors).
Peak ‘1’ corresponds to excitation at 280 nm and emission
at 330–340 nm (for HSA and lysozyme) or 304 nm for insulin.
This peak corresponds to emission by the aromatic side-chains
of Trp and Tyr residues in proteins. Both these amino acids
have an absorbance peak at 280 nm, and are known to be
signicantly uorescent, while emission from Phe can be
neglected.30 Tyr uorescence is insensitive to the polarity of its
environment, and its emission maximum is always found
around 303–305 nm.1,2,57 Indeed, insulin contains four Tyr
residues, and no Trp, and in its 3D spectrum peak ‘1’ is located
at lem. ¼ 304 nm. By contrast, Trp emission is very sensitive to
the polarity of its environment and its uorescence peak shis
from above 350 nm in water down to almost 305 nm in very
nonpolar environments or when buried in a hydrophobic
protein core,1,2 like in the extreme case of azurin.58 The
quantum yields of Tyr and Trp uorescence are comparable.
However, Tyr uorescence in proteins is usually rather weak,
mostly for two reasons: its extinction coeﬃcient at 280 nm is
lower by a factor of four than that of Trp, and its emission
partially overlaps with the absorption spectrum of Trp, so that
Fo¨rster resonance energy transfer (FRET) can occur from Tyr to
Trp residues. Consistent with these considerations, peak ‘1’ in
HSA and lysozyme is dominated by Trp emission, and is located
at lem. values, typical for this amino acid, with a red shied
maximum for lysozyme, where the Trp residues are more
solvent exposed than the lone Trp residue of HSA.
Peak ‘2’ is the feature of protein 3D uorescence spectra that
has been claimed to be due to protein backbone emission. By
comparing the 3D uorescence spectra of Fig. 1, we note that
the wavelength of maximum emission for this peak is always
essentially coincident with that of peak ‘1’, even though the
latter varies signicantly from one protein to the other (HSA
MY: peak ‘1’, 330 nm; peak ‘2’, 331 nm; HSA DK: peak ‘1’,
336 nm; peak ‘2’, 340 nm; HSA IT: peak ‘1’, 332 nm; peak ‘2’,
334 nm; insulin: peak ‘1’, 304 nm, peak ‘2’, 302 nm; lysozyme:
peak ‘1’, 339 nm, peak ‘2’, 342 nm). This spectral similarity of
the uorescence is further exemplied by overlaying the emis-
sion spectra of HSA and insulin upon excitation at 220 and
280 nm in Fig. 2. Kasha's rule1,2,59 states that the position and
shape of the emission spectrum is independent of the excitation
wavelength, since uorescence occurs in appreciable yield only
from the lowest excited singlet state. Therefore, the observation
of a coincidence of the maximum emission wavelength for
peaks ‘1’ and ‘2’ is the rst indication that the uorescence
originates from the excitation of the same uorophore at
diﬀerent excitation wavelengths, and immediately suggests that
peak ‘2’ is due to excitation of a higher excited state of the
aromatic residues.RSC Adv., 2016, 6, 112870–112876 | 112873
Fig. 2 Normalised emission spectra (DK) of: (left panel) the proteins HSA (red) and insulin (blue), and (right panel) the aromatic amino acids Trp
(dark red) and Tyr (light blue), excited at 220 (dashed lines) and 280 nm (solid lines).
Fig. 3 Normalised 3D ﬂuorescence spectra (as contour maps) of Trp (left) and Tyr (right) solutions (MY). The spectra were normalised to 100 on
peak ‘1’.
Fig. 4 Excitation spectra (IT) of Trp (red solid line) and HSA (blue solid
line). For comparison, the absorption spectrum of Trp and HSA are also
reported (dashed lines). lem. ¼ 350 nm. The spectra were normalised






















































































View Article OnlinePeak ‘2’ is due to aromatic residues
To further show that peak ‘2’ is due to the aromatic moieties
and not the protein backbone, we measured the 3D uores-
cence spectra of individual aromatic amino acids, which
therefore contain no amide bonds. Fig. 3 shows that peak ‘2’ is
present also for solutions of Trp and Tyr and that its position
corresponds roughly to those observed for Trp containing
proteins and for proteins with Tyr residues only, respectively
(Trp 353 nm; Tyr 303 nm).
There is a signicant diﬀerence for the observed emission
maximum of lysozyme and HSA (330–340 nm) and that of Trp
(350 nm), but this can be explained by the diﬀerent solvent
exposure of Trp in the various samples.1,2,31
Also in the case of Trp and Tyr, overlap of the normalised
emission spectra obtained with excitation at 220 nm and
280 nm (Fig. 2) conrms that the emitting species is the same.
Finally, Fig. 4 reports the excitation and absorption spectra for
HSA and Trp, collected by measuring the emission intensity at
350 nm. For both samples, two bands are observed, peaked at
approximately 280 and 220 nm, conrming that the 3D peak
observed in the case of HSA and oen attributed to backbone112874 | RSC Adv., 2016, 6, 112870–112876 This journal is © The Royal Society of Chemistry 2016
Fig. 5 Normalised 3D ﬂuorescence spectra (as contour maps) of poly-L-alanine (MY, left), oligo-L-Arg (DK, center) and poly-L-Lys (IT, right),






















































































View Article Onlineemission, actually originates from the uorescence of aromatic
residues.30 The slight diﬀerences between the excitation spectra
of Trp and HSA can be attributed to the presence of Tyr residues
in the protein and to the occurrence of Tyr-to-Trp energy-
transfer, which contributes to the observed uorescence.
The identity of the excited states corresponding to the two
excitation peaks of Trp and Tyr (and therefore also of proteins)
has been the object of extensive experimental and theoretical
studies. Near UV light (280 nm) leads to excitation of quasi-
degenerate excited states termed 1La and
1Lb in Platt's nota-
tion. Excitation in the far UV (peak at 220 nm) brings molecules
in higher energy states called 1Ba and
1Bb.60–62 A small fraction of
these molecules then can undergo photoionization, but most
relax very rapidly to 1La and
1Lb, with subsequent uorescence
emission.63,64The protein backbone is non-uorescent
As a nal conrmation that the peptide backbone does not
contribute at all to protein uorescence, we measured 3D
uorescence spectra for a number of homopolypeptides con-
taining no aromatic residues (Fig. 5). In these cases, the 3D
uorescence spectra correspond to the spectrum observed for
the buﬀer alone (Fig. 1, bottom row, right), and contain only
scattering signals. That is, no uorescence signal is observed in
the region 300–350 nm, as is observed for the proteins con-
taining aromatic residues.Conclusions
Even though the polypeptide backbone absorbs in the far-UV
region, we show here that it emits no uorescence. The emis-
sion peak at 300–350 nm, observed in 3D uorescence spectra
upon excitation at 220–230 nm, oen claimed to be caused by
backbone emission, is in reality due to the excitation of higher
excited electronic states of the aromatic residues present in the
protein. Once the aromatic moieties reach these states by
absorption of far-UV light, they rapidly relax to the lowest
excited state and from there emit at the usual wavelengths of
300–350 nm, according to Kasha's rule. Therefore, this peak
reports simply on the local environment of the aromatic resi-
dues, just like the peak with excitation at 280 nm, and not on
the backbone conformation or secondary structure of the
protein.This journal is © The Royal Society of Chemistry 2016As illustrated in the introduction, this conclusion should
have been obvious to any expert in protein uorescence.
Nonetheless, this error has persisted for more than 8 years, and
we estimate that there are now well over 100 papers claiming to
have observed uorescence from the protein backbone. Unfor-
tunately, we are witnessing an alarming number of errors or
misinterpretations in several published uorescence studies
(for a discussion of this issue, see ref. 9, 54, 56 and 65–67). The
current paper hopefully contributes to a reassessment of one of
the possible pitfalls.Acknowledgements
ST thanks the University of Malaya (University Malaya Research
Grant, Grant Number: RG275-14AFR) for supporting this
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